“It would be better if the authors excluded MS patients who are receiving interferon-beta (a common drug used for the treatment of MS), as it is able to mask the possible effect of CoQ10 by decreasing the amount of tumor necrosis factor (TNF)-alpha and increasing interleukin-6.”